资讯

Imunon announces IMNN-001 abstract accepted for oral presentation at 2025 ASCO
IMUNON (IMNN) announced that an abstract highlighting new, highly encouraging, Overall Survival data from the Phase 2 OVATION 2 Study of ...
The Manila Times5 天
Nature's Fynd to Debut Fy Bites and Fy Culinary Base at the 2025 National Restaurant ...
Visit Nature's Fynd at Booth 1385, in the Organic & Natural Pavilion, South Hall, at the 2025 National Restaurant Association ...
IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting
Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 ...